Mira Pharmaceuticals, Inc.
MIRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001904286
No open-market purchases or sales by Mira Pharmaceuticals, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $2.19M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Mira Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +9 vs. Q2 2025
- Shares held
- 1.40M
- +395.1K (+39.5%) vs. Q2 2025
- Total value
- $1.89M
- +$682.3K (+56.4%) vs. Q2 2025
- New holders
- 10
- 9 more added
- Sold out
- 1
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $2.19M |
| Q1 2026 | 26 | $2.30M |
| Q4 2025 | 25 | $3.35M |
| Q3 2025 | 29 | $1.89M |
| Q2 2025 | 20 | $1.21M |
| Q1 2025 | 19 | $949.1K |
| Q4 2024 | 24 | $1.28M |
| Q3 2024 | 15 | $1.08M |
| Q2 2024 | 11 | $454.0K |
| Q1 2024 | 11 | $704.0K |
| Q4 2023 | 6 | $102.0K |
| Q3 2023 | 3 | $3.72K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Mira Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cross Staff Investments Inc | 359,401 | $488.8K | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 203,643 | $277.0K | 0.00% | +85,819+72.8% | Added |
| Geode Capital Management, LLC | 136,440 | $185.6K | 0.00% | +1,145+0.8% | Added |
| BlackRock, Inc. | 109,769 | $149.3K | 0.00% | +109,769 | New |
| Suncoast Equity Management | 103,289 | $140.5K | 0.01% | 00.0% | Unchanged |
| First American Bank | 50,000 | $68.0K | 0.00% | +30,000+150.0% | Added |
| State Street Corp | 49,100 | $66.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 46,700 | $63.5K | 0.00% | +46,700 | New |
| Two Sigma Investments, LP | 45,703 | $62.2K | 0.00% | +25,816+129.8% | Added |
| J.W. Cole Advisors, Inc. | 45,501 | $61.9K | 0.00% | +4,846+11.9% | Added |
| Northern Trust Corp | 43,732 | $59.5K | 0.00% | +30,137+221.7% | Added |
| XTX Topco Ltd | 35,923 | $48.9K | 0.00% | +14,050+64.2% | Added |
| International Assets Investment Management, LLC | 35,000 | $42.4K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 30,187 | $41.0K | 0.00% | +523+1.8% | Added |
| Creative Planning | 22,599 | $30.7K | 0.00% | 00.0% | Unchanged |
| AQR Capital Management LLC | 22,000 | $29.9K | 0.00% | +22,000 | New |
| Mariner, LLC | 16,500 | $22.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,196 | $17.0K | 0.00% | +12,196 | New |
| Cary Street Partners Financial LLC | 10,000 | $13.6K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 7,000 | $9.52K | 0.00% | +7,000 | New |
| Citigroup Inc | 3,820 | $5.20K | 0.00% | +3,820 | New |
| Advisor Group Holdings, Inc. | 2,000 | $2.74K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,000 | $2.72K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,797 | $2.44K | 0.00% | +1,797 | New |
| EverSource Wealth Advisors, LLC | 365 | $496 | 0.00% | +365 | New |
| UBS Group AG | 216 | $294 | 0.00% | −284−56.8% | Reduced |
| Bank of America Corp | 140 | $190 | 0.00% | +21+17.6% | Added |
| FMR LLC | 115 | $156 | 0.00% | +115 | New |
| Wells Fargo & Company | 23 | $31 | 0.00% | +23 | New |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −773−100.0% | Sold out |